Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
729 pending office actions • 241 clients • 631 examiners • 252 art units • 20 of 729 (3%) have an AI response strategy ready
Sterne, Kessler, Goldstein & Fox P.L.L.C. manages 45633 career applications, primarily within the Biotechnology & Pharmaceuticals technology area. The firm maintains a resolved allowance rate of 90.37 percent. This rate of success is achieved with an average of 2.89 office actions per allowance.
Currently, the firm has 554 pending office actions. This workload reflects its role in life sciences prosecution. Practitioners can use the 2.89 average office actions per allowance to set client expectations regarding the duration of the examination process. The 90.37 percent resolved allowance rate indicates the firm's ability to overcome rejections in the Biotechnology & Pharmaceuticals sector. With 45633 career applications, the firm demonstrates experience in handling patent portfolios. The 554 pending office actions show that the firm continues to be active in the biotechnology field. This volume of applications and the corresponding success rate provide a comprehensive view of the firm's historical performance. Clients in the pharmaceutical sector can evaluate these metrics when planning their intellectual property strategies.
Based on the USPTO statutory response window for each pending office action. 207 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 207 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 21 (3%) |
| §101 + other | 99 (14%) |
| §103 only | 225 (31%) |
| §102 only | 31 (4%) |
| §112 only | 40 (5%) |
| Double-patenting only | 28 (4%) |
| Double-patenting + other | 59 (8%) |
| Multi-statute (no §101) | 218 (30%) |
| No statute on record | 8 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRISTOL, LYNN ANNE | 5 | 63.4% | +39.9% |
| BOWEN, ADAM S | 5 | 96.5% | +2.4% |
| ASDJODI, MOHAMMADREZA | 4 | 59.1% | +46.9% |
| ALSOMAIRY, SARAH ABDOALATIF | 4 | 57.8% | +30.2% |
| FRONDA, CHRISTIAN L | 3 | 82.5% | +14.2% |
| STULII, VERA | 3 | 32.8% | +24.8% |
| BAYS, MARIE D | 3 | 74.5% | +19.5% |
| ALAM, MIRZA F | 3 | 74.3% | +33.9% |
| CASTRO, ALFONSO | 3 | 51.0% | +19.4% |
| ORTEGA, MARTIN NATHAN | 3 | 26.8% | +32.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18678629 | EXOGENOUS KETONE BLEND COMPOSITIONS FOR DELIVERY OF KETONE BODIES | FRONDA, CHRISTIAN L | 4d overdue |
| 19676472 | FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY | FRONDA, CHRISTIAN L | — |
| 19578476 | R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT | FRONDA, CHRISTIAN L | — |
| 18770367 | SOURCE/DRAIN EPITAXIAL STRUCTURES FOR SEMICONDUCTOR DEVICES | BOWEN, ADAM S | — |
| 18746930 | SOURCE/DRAIN STRUCTURE FOR SEMICONDUCTOR DEVICE | BOWEN, ADAM S | — |
| 18741963 | Contact Structures In Semiconductor Devices | BOWEN, ADAM S | — |
| 18671732 | Contact Structures With Deposited Silicide Layers | BOWEN, ADAM S | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18459715 | ELIMINATION OF NEGATIVE COMPONENT OF UNIPOLAR ATRIAL ELECTROGRAM AND SIGNALING OF SAME | SCHAETZLE, KENNEDY | 168d overdue |
| 16423491 | BEAD COMPOSITIONS FOR AQUATIC WEED CONTROL | SAEED, ALI S | 147d overdue |
| 18232719 | METHOD OF FORMING BIOLOGICAL FIELD EFFECT TRANSISTORS INTEGRATED WITH HEATERS | BAUMAN, SCOTT E | 146d overdue |
| 17714597 | SYSTEM AND METHOD FOR A PAYMENT CARD-BASED EXECUTION OF A MULTIPARTY TRANSACTION INVOLVING ELECTRONIC FUNDS DISBURSEMENT | MADAMBA, CLIFFORD B | 112d overdue |
| 17875206 | HARDENED INTERLAYER DIELECTRIC LAYER | CRITE, ANTONIO B | 100d overdue |
| 13647325 | POINT-OF-CARE FLUIDIC SYSTEMS AND USES THEREOF | TURK, NEIL N | 98d overdue |
| 17311262 | COMPOSITIONS FOR STABILIZING BACTERIA AND USES THEREOF | MARTIN, RACHEL E | 88d overdue |
| 17629091 | A METHOD TO ASSIST IN THE EARLY DIAGNOSIS OF PANCREATIC ADENOCARCINOMA | BICKHAM, DAWN MARIE | 73d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17431044 | COMBINATIONS OF BINDING MOIETIES THAT BIND EGFR, HER2 AND HER3 | ALSOMAIRY, SARAH ABDOALATIF | 30d overdue |
| 18678629 | EXOGENOUS KETONE BLEND COMPOSITIONS FOR DELIVERY OF KETONE BODIES | FRONDA, CHRISTIAN L | 4d overdue |
| 18617190 | ENZYMATIC DETERGENT COMPOSITION WITH AMINO ACID | ASDJODI, MOHAMMADREZA | 4d overdue |
| 18990538 | BED DEVICE SYSTEM AND METHODS | ALAM, MIRZA F | 21d |
| 19242715 | COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE | BRISTOL, LYNN ANNE | 34d |
| 17556923 | SYSTEMS AND METHODS FOR ANALYTE DETECTION | ORTEGA, MARTIN NATHAN | 34d |
| 18364620 | COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE | BRISTOL, LYNN ANNE | 39d |
| 18177571 | HUMANIZED 3E10 ANTIBODIES, VARIANTS, AND ANTIGEN BINDING FRAGMENTS THEREOF | BRISTOL, LYNN ANNE | 47d |
| Client (Assignee) | Pending OAs |
|---|---|
| TSMC | 73 |
| Apple | 48 |
| Abbott Laboratories | 43 |
| ROKU, INC. | 36 |
| Capital One | 28 |
| adidas | 27 |
| American Express | 18 |
| MERUS N.V. | 17 |
| Bristol-Myers Squibb | 15 |
| Thule Sweden AB | 14 |
| SAP SE | 11 |
| Henkel | 11 |
| PepsiCo | 11 |
| Therabody, Inc. | 8 |
| KetoneAid, Inc. | 7 |
| Eight Sleep | 7 |
| MESOBLAST INTERNATIONAL SÁRL | 7 |
| SAREPTA THERAPEUTICS, INC. | 7 |
| Bigfoot Biomedical | 7 |
| Sphere Entertainment Group, LLC | 6 |
| Audi | 6 |
| Labrador Diagnostics | 6 |
| OXYLABS, UAB | 5 |
| NEUSTAR, INC. | 5 |
| GAMMADELTA THERAPEUTICS LIMITED | 5 |
| NEURACLE SCIENCE CO., LTD. | 4 |
| Momentive | 4 |
| IQE plc | 4 |
| Adienne Pharma & Biotech SA | 3 |
| Legalon Technologies | 3 |
| Extreme Networks | 3 |
| AstraZeneca | 3 |
| The MITRE Corporation | 3 |
| Asa Technologies, Corporation | 3 |
| Kriya Therapeutics, Inc. | 3 |
| Intrabio Ltd. | 3 |
| Kai R&D Center | 3 |
| MEDIMMUNE LIMITED | 3 |
| IMPACT THERAPEUTICS (SHANGHAI), INC | 3 |
| KH Neochem | 3 |
| NUOL Green Chemistry LLC | 3 |
| UPL | 3 |
| UAB | 3 |
| Airbus | 2 |
| Yondr | 2 |
| Viridian Therapeutics, Inc. | 2 |
| Moolec Science Limited | 2 |
| One Media, LLC | 2 |
| Mercari, Inc. | 2 |
| Petrobras | 2 |
| Art Unit | Apps |
|---|---|
| 3791 | 23 |
| 3732 | 17 |
| 1643 | 14 |
| 1642 | 10 |
| 2893 | 8 |
| 1629 | 7 |
| 1646 | 7 |
| 3796 | 6 |
| 3626 | 6 |
| 3691 | 6 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18798406 | Untitled | Capital One Services, LLC | WAMBST, DAVID ALEXANDER | Other | Non-Final OA | — | Pending | ||
| 18824237 | Untitled | Apple Inc. | LEE, JYE-JUNE | 2838 | §103 | Non-Final OA | — | Pending | |
| 19676472 | FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY | Ketoneaid, Inc. | FRONDA, CHRISTIAN L | 1652 | §103DP | Non-Final OA | — | Pending | May 13, 2026 |
| 19578476 | R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT | Ketoneaid, Inc. | FRONDA, CHRISTIAN L | 1652 | §103DP | Non-Final OA | — | Pending | Mar 25, 2026 |
| 19534368 | BEVERAGE CONTAINING R 1,3 BUTANEDIOL | Ketoneaid, Inc. | STULII, VERA | 1791 | §102§103 | Final Rejection | — | Pending | Feb 09, 2026 |
| 19441524 | CUSHIONING ELEMENT FOR A SHOE COMPRISING A SPIRAL GRID STRUCTURE | Adidas AG | BAYS, MARIE D | 3732 | §102§112 | Non-Final OA | — | Pending | Jan 06, 2026 |
| 19421433 | HINGE ARRANGEMENT FOR AN AIRCRAFT WING | Airbus Operations Limited | KREINER, MICHAEL B | 3642 | §103 | Non-Final OA | — | Pending | Dec 16, 2025 |
| 19421562 | WEARABLE DEVICES AND METHODS FOR PROVIDING THERAPY TO A USER AND/OR FOR MEASURING PHYSIOLOGICAL PARAMETERS OF THE USER | Therabody, Inc. | XU, JUSTIN | 3791 | §103DP | Final Rejection | — | Pending | Dec 16, 2025 |
| 19410753 | FOOTWEAR COMPRISING RIGID CAGE AND VARIABLE PADDING ELEMENT | Adidas AG | LYNCH, MEGAN E | 3732 | §102§103 | Non-Final OA | — | Pending | Dec 05, 2025 |
| 19402343 | INNER LINING BOOTIE COMPRISING MEMBRANE MATERIAL | Adidas AG | MANGINE, HEATHER N | 3732 | §103§112 | Non-Final OA | — | Pending | Nov 26, 2025 |
| 19381720 | SYSTEMS AND METHODS FOR DETECTING A PHYSIOLOGICAL FEATURE OF A SUBJECT | Eight Sleep Inc. | MARLEN, TAMMIE K | 3796 | §103 | Non-Final OA | — | Pending | Nov 06, 2025 |
| 19380102 | SYSTEMS AND METHODS FOR TEMPERATURE REGULATION OF AN ARTICLE OF FURNITURE | Eight Sleep Inc. | GEDEON, DEBORAH TALITHA | 3673 | §103 | Final Rejection | — | Pending | Nov 05, 2025 |
| 19358118 | METHOD AND SYSTEM FOR GLYCEMIC PREDICTION AND DYNAMIC VISUALIZATION | Abbott Laboratories | XU, JUSTIN | 3791 | §101§103§112 | Non-Final OA | 56d | AI Ready | Oct 14, 2025 |
| 19350895 | METHODS AND SYSTEMS FOR CONTROLLING ACCESS TO AN ELECTRONIC DEVICE | Yondr, Inc. | CUMMING, WILLIAM D | 2645 | §103§112 | Final Rejection | — | Pending | Oct 06, 2025 |
| 19344040 | DOUBLE-STRANDED RNAI AGENTS AND COMPOSITIONS FOR REDUCING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND METHODS OF USE THEREOF | Silence Therapeutics GmbH | YU, DAVID TUYANG | 1635 | §103 | Non-Final OA | — | Pending | Sep 29, 2025 |
| 19306598 | OUTSOLE FOR A SHOE | Adidas AG | YE, XINWEN | 3732 | §102§103 | Non-Final OA | — | Pending | Aug 21, 2025 |
| 19302962 | ADDITIVELY MANUFACTURED FOOTWEAR SOLES | Adidas AG | NGUYEN, BAO-THIEU L | 3732 | §102§103§112DP | Final Rejection | 22d | Pending | Aug 18, 2025 |
| 19302239 | JAILED ENVIRONMENT RESTRICTING PROGRAMMATIC ACCESS TO MULTI-TENANT DATA | Capital One Services, LLC | PATEL, DIVESH | §101Other | Non-Final OA | — | Pending | Aug 18, 2025 | |
| 19297947 | FC FRAGMENTS THAT BIND FCRN AND METHODS OF USE | Paragon Therapeutics, Inc. | DAHLE, CHUN WU | 1641 | §103Other | Final Rejection | — | Pending | Aug 12, 2025 |
| 19295322 | PERCUSSIVE THERAPY DEVICE WITH ELECTRICALLY CONNECTED ATTACHMENT | Therabody, Inc. | MILLER, CHRISTOPHER E | 3785 | §103§112 | Non-Final OA | 13d | Pending | Aug 08, 2025 |
| 19289224 | Logistical Management System | Airspace Technologies, Inc. | SIMPSON, DIONE N | 3629 | §101Other | Non-Final OA | — | Pending | Aug 04, 2025 |
| 19286707 | EpigenAU/11: A NATURAL MATRIX WITH THERAPEUTIC ACTIVITY THROUGH A PHYSIOLOGICAL NETWORK MECHANISM OF ACTION (NOT PHARMACOLOGICAL) FOR RESTORING HOMEOSTASIS IN TISSUES INFILTRATED BY CANCER CELLS | Bios-Therapy, Physiological Systems For Health S.p.A. | MI, QIUWEN | 1655 | §112 | Final Rejection | — | Pending | Jul 31, 2025 |
| 19275631 | R-TRIHEXYPHENIDYL FOR TREATMENT OF MOVEMENT DISORDERS | The Children'S Mercy Hospital | SCHMITT, MICHAEL J | 1629 | §102§103 | Final Rejection | — | Pending | Jul 21, 2025 |
| 19266310 | DATA AGGREGATION BASED ON HASH MAP DATA STRUCTURES | SAP SE | PHAN, TUANKHANH D | §103Other | Non-Final OA | — | Pending | Jul 11, 2025 | |
| 19261363 | AUDIO DUPLICATION AND REDIRECTION SYSTEM | Roku, Inc. | LE, RONG | DP | Non-Final OA | — | Pending | Jul 07, 2025 | |
| 19247631 | METHODS AND SYSTEMS FOR GATHERING AND ANALYZING HUMAN BIOLOGICAL SIGNALS | Eight Sleep Inc. | ALAM, MIRZA F | §103Other | Non-Final OA | — | Pending | Jun 24, 2025 | |
| 19242715 | COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE | Viridian Therapeutics, Inc. | BRISTOL, LYNN ANNE | 1643 | §103§112DPOther | Final Rejection | 34d | Pending | Jun 18, 2025 |
| 19240354 | SECURE SMART CARD SIGNING DIGITAL DOCUMENTS AND VALIDATION | Capital One Services, LLC | SHEHNI, GHAZAL B | §101§103Other | Non-Final OA | — | Pending | Jun 17, 2025 | |
| 19233583 | HIGH EXPRESSION OF ANIMAL HEME PROTEIN IN PLANTS | Moolec Science Limited | STOCKDALE, JESSICA NICOLE | 1663 | §102§112DP | Non-Final OA | — | Pending | Jun 10, 2025 |
| 19233948 | VARIABLE-STEP AUTHENTICATION FOR COMMUNICATIONS IN CONTROLLED ENVIRONMENT | Global Tel*Link Corporation | JEUDY, JOSNEL | DP | Non-Final OA | — | Pending | Jun 10, 2025 | |
| 19232100 | ZERO TOUCH DEPLOYMENT AND DYNAMIC CONFIGURATION | Elo Touch Solutions, Inc. | PATEL, DHAIRYA A | §101§103 | Non-Final OA | — | Pending | Jun 09, 2025 | |
| 19230422 | SYSTEMS AND METHODS FOR MANAGING COMMUNICATIONS ACROSS DEVICES IN A RING NETWORK | Apple Inc. | KAZI, SAYEEM MUHAMMAD | §103 | Non-Final OA | — | Pending | Jun 06, 2025 | |
| 19230482 | HIERARCHICAL MANAGEMENT OF MULTIPLE COMMUNICATION NETWORKS | Apple Inc. | TRAN, JIMMY H | DP | Non-Final OA | — | Pending | Jun 06, 2025 | |
| 19228419 | EFFICIENCY AND POWER CONTROL OF TASKS HAVING COMPUTATION BOUND AND MEMORY BOUND PHASES | Apple Inc. | SONG, HUA JASMINE | 2139 | §102 | Non-Final OA | — | Pending | Jun 04, 2025 |
| 19228224 | SUPPORT PLATE CONFIGURED TO BE ARRANGED IN A SOLE STRUCTURE OF A SHOE | Adidas AG | NUNNERY, GRADY ALEXANDER | 3732 | §102§103 | Final Rejection | 29d | Pending | Jun 04, 2025 |
| 19226678 | AIRCRAFT STRUCTURE | Airbus Operations Limited | BONNETTE, RODNEY ANDREW | 3733 | §102§103§112DP | Non-Final OA | — | Pending | Jun 03, 2025 |
| 19223354 | SYSTEM DISCOVERY AND SIGNALING | One Media, LLC | BURD, KEVIN MICHAEL | §102DP | Non-Final OA | — | Pending | May 30, 2025 | |
| 19222541 | MULTI CHAMBER FLEXIBLE BAG AND METHODS OF USING SAME | Adienne Pharma & Biotech SA | BOSWORTH, KAMI A | 3783 | §102§103§112 | Non-Final OA | — | Pending | May 29, 2025 |
| 19216367 | ROBOT TEACHING SYSTEM AND ROBOT CONTROL DEVICE | Daihen Corporation | EVANS, KARSTON G | §102§103§112 | Non-Final OA | — | Pending | May 22, 2025 | |
| 19209194 | METHODS AND SYSTEMS FOR CONTINUOUS ANALYTE MONITORING | Abbott Laboratories | AZIZ, ADNAN | §103§112 | Non-Final OA | — | Pending | May 15, 2025 | |
| 19205572 | MESSAGE PROCESSING USING A CLIENT-SIDE CONTROL GROUP | Roku, Inc. | DINH, KHANH Q | DP | Non-Final OA | — | Pending | May 12, 2025 | |
| 19200015 | PRESENTATION, TIMING AND SCHEDULE MANAGEMENT FOR BROADCAST PROGRAMMING IN BETTING APPLICATIONS | Sinclair Broadcast Group, LLC | BOYD, JONATHAN A | 2627 | §103 | Non-Final OA | — | Pending | May 06, 2025 |
| 19196382 | AUTOMATED ANALYSIS AND DYNAMIC SELECTION (CREATION) OF HIGH QUALITY SUPPLEMENTAL CONTENT FOR USER ENGAGEMENT OPTIMIZATION | Roku, Inc. | CASTRO, ALFONSO | 2421 | §103 | Non-Final OA | — | Pending | May 01, 2025 |
| 19196275 | UPPER WITH MEMBRANE REGIONS | Adidas AG | DUCKWORTH, BRIANNA T | 3732 | §102§103§112 | Final Rejection | 39d | Pending | May 01, 2025 |
| 19193451 | SELECTING MANAGED PROXY IP DEVICES BY GEOGRAPHICAL COORDINATES THEREOF | Oxylabs, Uab | SERRAO, RANODHI N | 2447 | §102Other | Non-Final OA | — | Pending | Apr 29, 2025 |
| 19125445 | MOTION GENERATION APPARATUS | Anthony Best Dynamics Ltd. | AWAD, AMR A | §102§112 | Non-Final OA | — | Pending | Apr 29, 2025 | |
| 19192023 | SELF HEALING SCRIPTS FOR SCANNING DEVICE | Infinite Peripherals, Inc. | KNAPP, JUSTIN R | §101DP | Non-Final OA | — | Pending | Apr 28, 2025 | |
| 19189599 | COMPUTER-IMPLEMENTED METHOD AND INFORMATION PROCESSING SYSTEM | Legalon Technologies, Inc. | MENG, JAU SHYA | 2168 | §103 | Final Rejection | 3d overdue | Pending | Apr 25, 2025 |
| 19186809 | DATABASE LOCKING USING LOGICAL LOCK MECHANISM | Neustar, Inc. | RICHARDSON, JAMES E | 2169 | §103§112DP | Final Rejection | 31d overdue | Pending | Apr 23, 2025 |
| 19177360 | APPARATUS AND METHOD FOR CLEANING SEMICONDUCTOR WAFER | Taiwan Semiconductor Manufacturing Company. Ltd. | CORMIER, DAVID G | 1711 | §102§103§112 | Non-Final OA | — | Pending | Apr 11, 2025 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial90.4% of resolved applications prosecuted by Sterne, Kessler, Goldstein & Fox PLLC were allowed, across 45,633 applications in USPTO records.
2.89 office actions per allowed application on average.
729 pending office actions as of October 2026, for 241 clients, before 631 examiners in 252 art units.